000 01459 a2200397 4500
005 20250516173844.0
264 0 _c20140721
008 201407s 0 0 eng d
022 _a1543-8392
024 7 _a10.1021/mp400441d
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPereira, Junia M
245 0 0 _aInterplay of degradation, dissolution and stabilization of clarithromycin and its amorphous solid dispersions.
_h[electronic resource]
260 _bMolecular pharmaceutics
_cDec 2013
300 _a4640-53 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
650 0 4 _aBiological Availability
650 0 4 _aCellulose
_xanalogs & derivatives
650 0 4 _aChemistry, Pharmaceutical
_xmethods
650 0 4 _aClarithromycin
_xchemistry
650 0 4 _aCrystallization
_xmethods
650 0 4 _aDrug Stability
650 0 4 _aHydrogen-Ion Concentration
650 0 4 _aNanoparticles
_xchemistry
650 0 4 _aPolymers
_xchemistry
650 0 4 _aSolubility
700 1 _aMejia-Ariza, Raquel
700 1 _aIlevbare, Grace A
700 1 _aMcGettigan, Heather E
700 1 _aSriranganathan, Nammalwar
700 1 _aTaylor, Lynne S
700 1 _aDavis, Richey M
700 1 _aEdgar, Kevin J
773 0 _tMolecular pharmaceutics
_gvol. 10
_gno. 12
_gp. 4640-53
856 4 0 _uhttps://doi.org/10.1021/mp400441d
_zAvailable from publisher's website
999 _c23162725
_d23162725